BIBLIOGRAFIA CONSULTADA

1. Aitken, Moira L., Fiel, Stanley B. Cystic Fibrosis in: Disease-a-Month. January 1993.
2. Barbero, G. The Science and Humanity of Cystic Fibrosis. Curr Probl Pediatr. Dec. 1993.
3. Davis, Pamela . Cystic Fibrosis: State of the Art. Am J Respir Crit Care Med Vol 154 1996
4. Halliburton, Cory. Cystic Fibrosis Deaths in the United States from 1979 through 1991.
Arch Pediatr Adolesc Med. Vol 150, November 1996.
5. Orenstein, David. Cystic Fibrosis. Current Problems in Pediatrics. January 1993.
6. Ramsey, Bonnie. Management of Pulmonary Disease in Patients with Cystic Fibrosis.
The New England Journal of Medicine. Volume 335. Number 3.July 1996.
7. Sabella, Camille. Fluoroquinolone Therapy in Pediatrics: Where We Stand.
Clinical Pediatrics. August 1997.
8. Stern, Robert. The Diagnosis of Cystic Fibrosis. New Engl Jour Med. February 1997.
9. Wallis, C. Diagnosing Cystic Fibrosis: Blood, Sweat, and Tears. Arch Dis Child. 76-1997.
10. Wood, B. Cystic Fibrosis: 1997. Radiology. Vol 204 Num 1. July 1997.
11. Mickle, John E., Cutting, Garry. Genotype/Phenotype Relationship in Cystic Fibrosis.
The Medical Clinics of North America. Vol 84 Number 3
May 2000.

ANEXO 1

Bacterias asociadas con exacerbaciones de infección pulmonar en pacientes con Fibrosis Quística y tratamiento antibiótico. (6,7)
Bacteria Antibiótico Endovenoso Antibiótico Oral
S. aureus Cefalotina Dicloxacilina
Vancomicina Amoxicilina + Ac. Clavulánico
S. aureus + Ticarcilina/Ac. Clavulánico Cefixima
H. influenzae + Gentamicina Amoxicilina + Ac. Clavulánico
S. aureus + Ticarcilina/Ac. Clavulánico
P. aeruginosa + Tobramicina
P. aeruginosa Ticarcilina + Tobramicina Ciprofloxacina
Ofloxacina
P. aeruginosa + Ceftazidima +
P. cepacia Ciprofloxacina
P. cepacia Cloramfenicol TPM + SMX
TMP + SMX